Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2002

View Archived Issues

Effects of atorvastatin on reactive oxygen species may enhance vasoprotection

Enchira develops protein-based cancer therapeutics

Nabi changes name to Nabi Biopharmaceuticals

Novuspharma announces 2001 highlights

ISTA commences analysis of phase III Vitrase data

CPMP recommends approval of Avonex in early-stage MS

AxCell Biosciences and Thomas Jefferson University to study protein implicated in cancer

Pozen submits final mouse carcinogenicity results for MT-100

Fast track designation for CCI-779 in renal cell carcinoma

INS-37217 Intranasal proves promising in phase I trial

New treatment for digoxin toxicity or overdose available in the U.S.

Microbiotix develops pipeline of small-molecule antiinfective drugs; U.S. patent issued for lead

Blockade of the secretory process in mast cells as an approach to allergy Rx

Russian research yields polypeptide complex with efficacy in exudative AMD

Functional and morphological effects of Epitalon in rat model of retinitis pigmentosa

Inhibition of iNOS provides neuroprotection in glaucoma

Clinical data on alefacept a highlight of the AAD meeting

Rubitecan receives brand name Orathecin

Method for regeneration of nerve tissue described at the University of Texas

Scientists at GlaxoSmithKline design peptides binding to G-CSF receptor

Novel series of compounds for neurodegenerative disorders disclosed in patent literature

Angiogenesis inhibitors described by researchers at Angiogene Pharmaceuticals

Capsaicin receptor ligands for the treatment of pain in the Neurogen pipeline

Novel HIV inhibitors claimed by former DuPont

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...